## Abstract ## Objective Investigation of the characteristics of patients being treated with antidepressants would be useful in determining which patients would most likely benefit from antidepressant. The purpose of this study was to examine the possible predictors of response to sertraline in ma
Early response as predictor of final remission in elderly depressed patients
β Scribed by Rob M. Kok; Carlijn van Baarsen; Willem A. Nolen; Thea J. Heeren
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 63 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2261
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Several studies have attempted to predict the final response or remission based on improvement during the early course of treatment of major depression. There is however a great variation in cut offs used to define early response and in the optimal week to predict final results.
Objective
To compare different cut offs at different time points early in the treatment of elderly depressed patients.
Method
A 12 week randomised, controlled trial in 81 elderly inpatients with DSMβIV major depression comparing venlafaxine with nortriptyline. At least 20, 25, 30 or 50% improvement was analysed after 1, 3 and 5 weeks using the Hamilton Depression Rating Scale and the Montgomery Asberg Depression Rating Scale. We plotted sensitivity against 1βspecificity and calculated areas under the curve (AUCs).
Results
The highest percentage of correctly classified patients is found using at least 50% decrease as cut off in week 5, with acceptable sensitivity (81.8%) and specificity (87.4%). In week 5, the AUCs were 0.891 (95% CI 0.798β0.984) and 0.866 (95% CI 0.789β0.983) for the HAMβD and MADRS, respectively.
Conclusions
Combining the results from our study and the other studies addressing this issue, we suggest that the treatment should be changed in the elderly if after 3β4 weeks less than 30% improvement in depression score has been achieved. Copyright Β© 2009 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w
## Objectives This study established the value of the 6βsulfatoxymelatonin (aMT6s) urine concentration as a predictor of the therapeutic response to noradrenaline reuptake inhibitors in depressive patients. ## Methods Twentyβtwo women aged 18β60βyears were selected. Depressive symptoms were asses
## Abstract ## Introduction Clonazepam has been shown to be an effective supplementary treatment for depression. Thus, it would be useful to determine which patient characteristics are associated with response to clonazepam. ## Aims The purpose of this study was to examine the possible predictor